Personal profile
Expertises
Haemato-oncologist. Responsible for treatment of malignant lymphoma and for experimental/phase I treatment of haematological malignancies at Rigshospitalet. Head of service for Hodgkin lymphoma, Mantle cell lymphoma and Castleman’s disease.
Main research areas
Hodgkin lymphoma; Mantle cell lymphoma; PET/CT in lymphoma; PET-response adapted lymphoma treatment; Phase 1 haematology studies;
Current research
Chairman of the EORTC lymphoma group since 2013. Co-author of the international response criteria and guidelines for the use of imaging in lymphoma. Co-author of the European society of Medical Oncology (ESMO) guidelines for Hodgkin lymphoma and ’ultra high-risk’ lymphomas.
Faculty member for the EHA Clinical Research Training in Haematology programme
Member of the scientific committee for the European Haematology Association
National principal investigator or sub-investigator for >25 solid tumour and haematology phase I trials
National principal investigator for three mantle cell lymphoma trials (one ongoing and two planned) and three Hodgkin lymphoma trials.
Site principal investigator or sub-investigator for >20 lymphoma and myeloma phase II and phase III trials
Potential conflicts of interest
None
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
A real-world comparison of CD20xCD3 bispecific antibodies versus chemotherapy regimens in 3+ line relapsed/refractory diffuse large B cell lymphoma
Kyvsgaard, E. R., Fuglkjær, A. D., Al-Mashhadi, A. L., Hasselbalch Riley, C., Brown, P., Niemann, C. U., Christensen, J. H., Clausen, M. R., Grønbæk, K., Hutchings, M., Larsen, T. S., El-Galaly, T. C. & Husby, S., 11 Mar 2026, (E-pub ahead of print) In: Leukemia and Lymphoma.Research output: Contribution to journal › Letter › peer-review
-
Efficacy and safety of epcoritamab in relapsed or refractory large B-cell lymphoma: 3-year update from the EPCORE NHL-1 trial
Karimi, Y. H., Cheah, C. Y., Clausen, M. R., Cunningham, D., Farooq, U., Feldman, T., Ghesquieres, H., Jurczak, W., Linton, K. M., Phillips, T., Vose, J. M., Kim, W. S., Jafarinasabian, P., D'Angelo Månsson, B., Soong, D., Steele, A. J., Li, Z., Eskelund, C. W., Hutchings, M. & Thieblemont, C., 4 Feb 2026, In: Annals of Hematology. 105, 3, p. 79 79.Research output: Contribution to journal › Journal article › Research › peer-review
-
Epidemiological evidence for the role of puberty and immune senescence in Hodgkin lymphoma aetiology from 1992 Danish cases
Rostgaard, K., Hamilton-Dutoit, S., Lauridsen, K. L., Ottander, L., Plesner, T. L., Hollander, P., Brown, P., Sjö, L., Johansen, C., Kamper, P., Høgdall, E., d'Amore, F., Specht, L., Jarrett, R. F., McKay, J. D., Hutchings, M., Hjalgrim, L. L., Glimelius, I. & Hjalgrim, H., 2026, In: International Journal of Cancer. 158, 10, p. 2629-2640 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
1 Citation (Scopus) -
Impact of prior bendamustine exposure on bispecific antibody outcomes in relapsed/refractory follicular lymphoma
Iacoboni, G., Kyvsgaard, E. R., Navarro Garcés, V., Russler-Germain, D. A., Lewis, K., Martín García-Sancho, A., Carro, I., Thompson, P. A., Therwhanger, D., Quintela, D., Ku, M., Gómez, P., Valencia, E., Vega, G., Jiménez-Ubieto, A., Bastos-Oreiro, M., Serna, A., Husby, S., De La Cruz, B. & Luan, J. & 13 others, , 24 Mar 2026, In: Blood advances. 10, 6, p. 1947-1951 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Prevalence of Pre-Treatment Sarcopenia in Patients Newly Diagnosed with Lymphoma
Grønset, C. N., Jarden, M., Christensen, J., Hutchings, M., Tolver, A. & Suetta, C., Mar 2026, In: Acta Haematologica. 149, 2, p. 187–197 11 p.Research output: Contribution to journal › Journal article › Research › peer-review